# Real-time, label-free impedimetric monitoring of insulin secretion from three-dimensional stem cell-derived islets

Article · Zitzmann FD, Remmert C, Rogers NK, Schmidt S, Lickert H, Jahnke HG, Meier M

- Archive id: doi:10.1016/j.bios.2026.118720
- Published: 2026-04-24
- Venue: Biosensors & bioelectronics
- DOI: https://doi.org/10.1016/j.bios.2026.118720
- PMID: 42054864
- Citations: 0
- Source URL: https://doi.org/10.1016/j.bios.2026.118720
- Provenance: europepmc

## Abstract

Functional assessment of insulin secretion is essential for the development and application of stem cell-derived β-cell products. Conventional glucose-stimulated insulin secretion (GSIS) assays rely on end-point, batch-averaged enzyme-linked immunosorbent assays (ELISA), limiting temporal resolution and masking functional heterogeneity at the level of individual islet-like clusters. Here, we present a label-free, non-invasive impedance spectroscopy-based approach for real-time monitoring of insulin secretion from individual stem cell-derived islets (SC-islets) cultured on microcavity microelectrode array (MEA) chips. Human induced pluripotent stem cells were differentiated into SC-islets and integrated into microcavity MEAs, enabling three-dimensional confinement and parallel electrical recordings. Impedance measurements during on-chip GSIS revealed characteristic glucose-responsive dynamics that correlated with insulin secretion quantified by ELISA and were suppressed by pharmacological inhibition. Impedance spectroscopy resolved functional responses at the level of individual SC-islets, uncovering cluster-to-cluster variability that was obscured by pooled secretion assays. High-density microcavity MEAs further enabled spatially resolved impedance measurements, revealing intra-cluster heterogeneity of insulin secretion. While impedance spectroscopy provides an indirect readout and glucose stimulation was applied as stepwise changes, this platform enables real-time, scalable, and cluster-resolved functional assessment of three-dimensional islet tissues. The approach establishes a foundation for functional screening of SC-islets, differentiation optimization, drug testing, and future potency assessment workflows.

_Abstract reproduced under CC-BY (article license as recorded by Europe PMC; abstract reproduced unmodified apart from markup removal)._

Topics: [Gene & Cell Therapy](https://space-kitty.com/topics/gene-cell-therapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.